Home
HelpTest Code CHEM14 Urine Drug Screen 10
Clinical Information
This test is intended to screen for the presence of amphetamine/methamphetamines, barbiturates, benzodiazepines, buprenorphine, cannabinoids, cocaine, fentanyl, methadone, opiates, and/or oxycodone. Results are reported as 'presumptive positive' and are not confirmed.
Synonym
- 10DRUG
Profile Information
| Reporting Name | Available Separately | Always Reported |
|---|---|---|
| Amphetamine/Methamphetamine | No | Yes |
| Barbiturates | No | Yes |
| Benzodiazepines | No | Yes |
| Buprenorphine | No | Yes |
| Cannabinoids (Marijuana) | No | Yes |
| Cocaine | No | Yes |
| Fentanyl | No | Yes |
| Methadone | No | Yes |
| Opiates | No | Yes |
| Oxycodone | No | Yes |
Specimen Required
Preferred Container/Tube: Urine Container Cup
Acceptable Container/Tube: Urine Container Cup, Urine
Specimen Volume: 3 mL
Specimen Minimum Volume: 1 mL
Specimen Stability Information
Ambient: 5 days
Refrigerated: 5 days
Rejection Due To
- Quantity not sufficient
Reference Values
None Detected
Cutoff concentrations by immunoassay detection:
Amphetamine/Methamphetamine: 500 ng/mL
Barbiturates: 200 ng/mL
Benzodiazepines: 200 ng/mL
Buprenorphine: 5 ng/mL
Cannabinoids: 50 ng/mL
Cocaine: 150 ng/mL
Fentanyl: 1 ng/mL
Methadone: 300 ng/mL
Opiates: 300 ng/mL
Oxycodone: 100 ng/mL
Interpretation
Presumptive positive results indicate the presence of a compound within the specified class of drugs or a structurally related compound in the urine sample. Negative results may reflect the absence of drug or drug present below the assay's limit of detection. The detection of drugs in urine is dependent on several factors such as the amount of drug ingested, time since exposure, individual metabolism, kidney and liver function, urine concentration, and the assay's limit of detection.
Cautions
Detection of drugs in urine is dependent on urine concentration. False negative results may occur in urine that has been diluted either by direct sample tampering or by ingesting large quantities of water before sample collection.
Method Description
Beckman Coulter DxC700AU: Emit® II Plus Amphetamines Assay, Barbiturates Assay, Benzodiazepine Assay, Buprenorphine Assay, Cannabinoids Assay, Cocaine Metabolite Assay, Methadone Assay, and Opiates Assay. ARK™ Fentanyl II Assay. DRI® Oxycodone Assay.
Performing Lab
Clinical Lab UH
Clinical Lab University East
Clinical Lab James
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 day
Reporting Name
Urine Drug Screen 10
CPT Code Information
80307
LOINC Code Information
33280-9
3377-9
3390-2
3414-0
18282-4
3397-7
11235-9
3773-9
3879-4
10998-3